Feagan BG, Sands BE, Sandborn WJ, Germinaro M, et al. Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial. Lancet Gastroenterol Hepatol 2023 Feb 1:S2468-1253(22)00427.
PMID: 36738762